Cocrystal Pharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell COCP and other ETFs, options, and stocks.About COCP
Cocrystal Pharma, Inc. is a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication process of influenza viruses, coronaviruses (including SARS-CoV-2), noroviruses and hepatitis C viruses. Cocrystal employs unique structure-based technologies to create first- and best-in-class antiviral drugs.
CEOSam Lee
CEOSam Lee
Employees11
Employees11
HeadquartersBothell, Washington
HeadquartersBothell, Washington
Founded2008
Founded2008
Employees11
Employees11
COCP Key Statistics
Market cap13.56M
Market cap13.56M
Price-Earnings ratio-0.83
Price-Earnings ratio-0.83
Dividend yield—
Dividend yield—
Average volume83.27K
Average volume83.27K
High today$1.05
High today$1.05
Low today$1.02
Low today$1.02
Open price$1.05
Open price$1.05
Volume39.01K
Volume39.01K
52 Week high$3.26
52 Week high$3.26
52 Week low$1.00
52 Week low$1.00
Stock Snapshot
The current Cocrystal Pharma(COCP) stock price is $1.03, with a market capitalization of 13.56M. The stock trades at a price-to-earnings (P/E) ratio of -0.83.
On 2025-11-16, Cocrystal Pharma(COCP) stock traded between a low of $1.02 and a high of $1.05. Shares are currently priced at $1.03, which is +1.0% above the low and -1.9% below the high.
Cocrystal Pharma(COCP) shares are trading with a volume of 39.01K, against a daily average of 83.27K.
In the last year, Cocrystal Pharma(COCP) shares hit a 52-week high of $3.26 and a 52-week low of $1.00.
In the last year, Cocrystal Pharma(COCP) shares hit a 52-week high of $3.26 and a 52-week low of $1.00.
People also own
Based on the portfolios of people who own COCP. This list is generated using Robinhood data, and it’s not a recommendation.